{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T22:58:38Z","timestamp":1791241118903,"version":"4.1.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T00:00:00Z","timestamp":1783641600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T00:00:00Z","timestamp":1791244800000},"content-version":"vor","delay-in-days":88,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100005851","name":"Shahid Beheshti University of Medical Sciences","doi-asserted-by":"publisher","award":["43005434"],"award-info":[{"award-number":["43005434"]}],"id":[{"id":"10.13039\/501100005851","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cancer Res Clin Oncol"],"DOI":"10.1007\/s00432-026-06550-5","type":"journal-article","created":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T01:51:24Z","timestamp":1783648284000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Exploring the potential role of miR-124 in angiogenesis in colorectal cancer"],"prefix":"10.1007","volume":"152","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8984-7229","authenticated-orcid":false,"given":"Ali","family":"Ahmadizad Firouzjaei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazem","family":"Sharifi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samira","family":"Mohammadi-Yeganeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyed Hamid","family":"Aghaee-Bakhtiari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,10]]},"reference":[{"issue":"5","key":"6550_CR1","doi-asserted-by":"publisher","first-page":"471","DOI":"10.3390\/cells8050471","volume":"8","author":"RG Akwii","year":"2019","unstructured":"Akwii RG, Sajib MS, Zahra FT, Mikelis CM (2019) Role of angiopoietin-2 in vascular physiology and pathophysiology. Cells 8(5):471","journal-title":"Cells"},{"issue":"3","key":"6550_CR2","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1007\/s10456-021-09767-9","volume":"24","author":"F Baganha","year":"2021","unstructured":"Baganha F, de Jong RCM, Peters EA, Voorham W, Jukema JW, Delibegovic M, de Vries MR, Quax PHA (2021) Atorvastatin pleiotropically decreases intraplaque angiogenesis and intraplaque haemorrhage by inhibiting ANGPT2 release and VE-Cadherin internalization. Angiogenesis 24(3):567\u2013581","journal-title":"Angiogenesis"},{"issue":"3","key":"6550_CR3","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1080\/14737140.2018.1428092","volume":"18","author":"F Battaglin","year":"2018","unstructured":"Battaglin F, Puccini A, Intini R, Schirripa M, Ferro A, Bergamo F, Lonardi S, Zagonel V, Lenz HJ, Loupakis F (2018) The role of tumor angiogenesis as a therapeutic target in colorectal cancer. Expert Rev Anticancer Ther 18(3):251\u2013266","journal-title":"Expert Rev Anticancer Ther"},{"key":"6550_CR4","volume":"35","author":"MJ Bazyari","year":"2023","unstructured":"Bazyari MJ, Saadat Z, Firouzjaei AA, Aghaee-Bakhtiari SH (2023) Deciphering colorectal cancer progression features and prognostic signature by single-cell RNA sequencing pseudotime trajectory analysis. Biochem Biophys Rep 35:101491","journal-title":"Biochem Biophys Rep"},{"key":"6550_CR5","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241411489","author":"A Bogaczyk","year":"2023","unstructured":"Bogaczyk A, Zawlik I, Zuzak T, Kluz M, Potocka N, Kluz T (2023) The role of miRNAs in the development, proliferation, and progression of endometrial cancer. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms241411489","journal-title":"Int J Mol Sci"},{"key":"6550_CR6","doi-asserted-by":"publisher","DOI":"10.3390\/ijms222212389","author":"M Buttacavoli","year":"2021","unstructured":"Buttacavoli M, Di Cara G, Roz E, Pucci-Minafra I, Feo S, Cancemi P (2021) Integrated multi-omics investigations of metalloproteinases in colon cancer: focus on MMP2 and MMP9. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms222212389","journal-title":"Int J Mol Sci"},{"issue":"1","key":"6550_CR7","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1038\/s41598-021-03952-y","volume":"12","author":"F Chionh","year":"2022","unstructured":"Chionh F, Gebski V, Al-Obaidi SJ, Mooi JK, Bruhn MA, Lee CK, Ch\u00fceh AC, Williams DS, Weickhardt AJ, Wilson K, Scott AM, Simes J, Hardingham JE, Price TJ, Mariadason JM, Tebbutt NC (2022) VEGF-A, VEGFR1 and VEGFR2 single nucleotide polymorphisms and outcomes from the AGITG MAX trial of capecitabine, bevacizumab and mitomycin C in metastatic colorectal cancer. Sci Rep 12(1):1238","journal-title":"Sci Rep"},{"key":"6550_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2022.110580","volume":"104","author":"L Darvish","year":"2023","unstructured":"Darvish L, Bahreyni Toossi MT, Azimian H, Shakeri M, Dolat E, Ahmadizad Firouzjaei A, Rezaie S, Amraee A, Aghaee-Bakhtiari SH (2023) The role of microRNA-induced apoptosis in diverse radioresistant cancers. Cell Signal 104:110580","journal-title":"Cell Signal"},{"issue":"11","key":"6550_CR9","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1007\/s00384-008-0511-3","volume":"23","author":"LF Fan","year":"2008","unstructured":"Fan LF, Dong WG, Jiang CQ, Qian Q, Yu QF (2008) Role of hypoxia-inducible factor-1 alpha and Survivin in colorectal carcinoma progression. Int J Colorectal Dis 23(11):1057\u20131064","journal-title":"Int J Colorectal Dis"},{"issue":"8","key":"6550_CR10","doi-asserted-by":"publisher","first-page":"1488","DOI":"10.1002\/cbf.3889","volume":"41","author":"AA Firouzjaei","year":"2023","unstructured":"Firouzjaei AA, Aghaee-Bakhtiari SH, Tafti A, Sharifi K, Abadi M, Rezaei S, Mohammadi-Yeganeh S (2023a) Impact of curcumin on ferroptosis-related genes in colorectal cancer: insights from in-silico and in-vitro studies. Cell Biochem Funct 41(8):1488\u20131502","journal-title":"Cell Biochem Funct"},{"issue":"1","key":"6550_CR11","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1111\/cbdd.14242","volume":"102","author":"AA Firouzjaei","year":"2023","unstructured":"Firouzjaei AA, Sharifi K, Khazaei M, Mohammadi-Yeganeh S, Aghaee-Bakhtiari SH (2023b) Screening and introduction of key cell cycle microRNAs deregulated in colorectal cancer by integrated bioinformatics analysis. Chem Biol Drug des 102(1):137\u2013152","journal-title":"Chem Biol Drug des"},{"issue":"6","key":"6550_CR12","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.1158\/0008-5472.CAN-12-4697","volume":"73","author":"D Gerald","year":"2013","unstructured":"Gerald D, Chintharlapalli S, Augustin HG, Benjamin LE (2013) Angiopoietin-2: an attractive target for improved antiangiogenic tumor therapy. Cancer Res 73(6):1649\u20131657","journal-title":"Cancer Res"},{"issue":"11","key":"6550_CR13","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1111\/j.1365-2362.2007.01866.x","volume":"37","author":"A Giatromanolaki","year":"2007","unstructured":"Giatromanolaki A, Koukourakis MI, Sivridis E, Chlouverakis G, Vourvouhaki E, Turley H, Harris AL, Gatter KC (2007) Activated VEGFR2\/KDR pathway in tumour cells and tumour associated vessels of colorectal cancer. Eur J Clin Invest 37(11):878\u2013886","journal-title":"Eur J Clin Invest"},{"key":"6550_CR14","doi-asserted-by":"publisher","first-page":"221","DOI":"10.3389\/fonc.2020.00221","volume":"10","author":"Y Haibe","year":"2020","unstructured":"Haibe Y, Kreidieh M, El Hajj H, Khalifeh I, Mukherji D, Temraz S, Shamseddine A (2020) Resistance mechanisms to anti-angiogenic therapies in cancer. Front Oncol 10:221","journal-title":"Front Oncol"},{"key":"6550_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2021.120234","volume":"290","author":"M Hosseini","year":"2022","unstructured":"Hosseini M, Baghaei K, Hajivalili M, Zali MR, Ebtekar M, Amani D (2022) The anti-tumor effects of CT-26 derived exosomes enriched by MicroRNA-34a on murine model of colorectal cancer. Life Sci 290:120234","journal-title":"Life Sci"},{"issue":"4","key":"6550_CR16","doi-asserted-by":"publisher","first-page":"65","DOI":"10.3390\/ijms19041232","volume":"19","author":"Y Itatani","year":"2018","unstructured":"Itatani Y, Kawada K, Yamamoto T, Sakai Y (2018) Resistance to anti-angiogenic therapy in cancer-alterations to anti-VEGF pathway. Int J Mol Sci 19(4):65","journal-title":"Int J Mol Sci"},{"issue":"3","key":"6550_CR17","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1111\/cbdd.12671","volume":"87","author":"F Karami","year":"2016","unstructured":"Karami F, Mohammadi-Yeganeh S, Abedi N, Koochaki A, Kia V, Paryan M (2016) Bioinformatics prediction and in vitro analysis revealed that miR-17 targets cyclin D1 mRNA in triple negative breast cancer cells. Chem Biol Drug des 87(3):317\u2013320","journal-title":"Chem Biol Drug des"},{"issue":"1","key":"6550_CR18","doi-asserted-by":"publisher","first-page":"123","DOI":"10.2174\/1573412916666200120155104","volume":"22","author":"Y Khazaei-Poul","year":"2021","unstructured":"Khazaei-Poul Y, Farhadi S, Ghani S, Ahmadizad SA, Ranjbari J (2021) Monocyclic peptides: types, synthesis and applications. Curr Pharm Biotechnol 22(1):123\u2013135","journal-title":"Curr Pharm Biotechnol"},{"issue":"3","key":"6550_CR19","first-page":"1160","volume":"53","author":"A Kim","year":"2018","unstructured":"Kim A, Ma JY (2018) Rhaponticin decreases the metastatic and angiogenic abilities of cancer cells via suppression of the HIF-1\u03b1 pathway. Int J Oncol 53(3):1160\u20131170","journal-title":"Int J Oncol"},{"issue":"1","key":"6550_CR20","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.jss.2013.05.020","volume":"185","author":"LJ Kuo","year":"2013","unstructured":"Kuo LJ, Hung CS, Chen WY, Chang YJ, Wei PL (2013) Glucose-regulated protein 78 silencing down-regulates vascular endothelial growth factor\/vascular endothelial growth factor receptor 2 pathway to suppress human colon cancer tumor growth. J Surg Res 185(1):264\u2013272","journal-title":"J Surg Res"},{"issue":"10","key":"6550_CR21","first-page":"4163","volume":"30","author":"HC Kwon","year":"2010","unstructured":"Kwon HC, Kim SH, Oh SY, Lee S, Kwon KA, Choi HJ, Park KJ, Kim HJ, Roh MS (2010) Clinicopathological significance of p53, hypoxia-inducible factor 1alpha, and vascular endothelial growth factor expression in colorectal cancer. Anticancer Res 30(10):4163\u20134168","journal-title":"Anticancer Res"},{"key":"6550_CR22","doi-asserted-by":"publisher","first-page":"1055019","DOI":"10.3389\/fonc.2022.1055019","volume":"12","author":"D Lavacchi","year":"2022","unstructured":"Lavacchi D, Fancelli S, Roviello G, Castiglione F, Caliman E, Rossi G, Venturini J, Pellegrini E, Brugia M, Vannini A, Bartoli C, Cianchi F, Pillozzi S, Antonuzzo L (2022) Mutations matter: an observational study of the prognostic and predictive value of KRAS mutations in metastatic colorectal cancer. Front Oncol 12:1055019","journal-title":"Front Oncol"},{"issue":"2","key":"6550_CR23","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.jtho.2020.10.006","volume":"16","author":"X Le","year":"2021","unstructured":"Le X, Nilsson M, Goldman J, Reck M, Nakagawa K, Kato T, Ares LP, Frimodt-Moller B, Wolff K, Visseren-Grul C, Heymach JV, Garon EB (2021) Dual EGFR-VEGF pathway inhibition: a promising strategy for patients with EGFR-mutant NSCLC. J Thorac Oncol 16(2):205\u2013215","journal-title":"J Thorac Oncol"},{"issue":"1","key":"6550_CR24","first-page":"71","volume":"79","author":"H Li","year":"2020","unstructured":"Li H, Zhao B, Liu Y, Deng W, Zhang Y (2020) Angiogenesis in residual cancer and roles of HIF-1\u03b1, VEGF, and MMP-9 in the development of residual cancer after radiofrequency ablation and surgical resection in rabbits with liver cancer. Folia Morphol (Warsz) 79(1):71\u201378","journal-title":"Folia Morphol (Warsz)"},{"issue":"10","key":"6550_CR25","doi-asserted-by":"publisher","first-page":"5925","DOI":"10.1007\/s12035-022-02958-5","volume":"59","author":"YT Liu","year":"2022","unstructured":"Liu YT, Lee CC, Lin CF, Wu HM, Guo WY, Yang HC, Chang FC, Liou KD, Lin CJ (2022) Plasma matrix metalloproeteinase-9 is associated with seizure and angioarchitecture changes in brain arteriovenous malformations. Mol Neurobiol 59(10):5925\u20135934","journal-title":"Mol Neurobiol"},{"issue":"1","key":"6550_CR26","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1186\/s13075-020-2145-y","volume":"22","author":"S Ma","year":"2020","unstructured":"Ma S, Zhang A, Li X, Zhang S, Liu S, Zhao H, Wu S, Chen L, Ma C, Zhao H (2020) MiR-21-5p regulates extracellular matrix degradation and angiogenesis in TMJOA by targeting Spry1. Arthritis Res Ther 22(1):99","journal-title":"Arthritis Res Ther"},{"issue":"6","key":"6550_CR27","first-page":"1","volume":"26","author":"S Mohammadi Yeganeh","year":"2017","unstructured":"Mohammadi Yeganeh S, Vasei M, Tavakoli R, Kia V, Paryan M (2017) The effect of miR-340 over-expression on cell-cycle-related genes in triple-negative breast cancer cells. Eur J Cancer Care (Engl) 26(6):1\u20136","journal-title":"Eur J Cancer Care (Engl)"},{"issue":"6","key":"6550_CR28","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1158\/1078-0432.CCR-15-1221","volume":"22","author":"KP Papadopoulos","year":"2016","unstructured":"Papadopoulos KP, Kelley RK, Tolcher AW, Razak AR, Van Loon K, Patnaik A, Bedard PL, Alfaro AA, Beeram M, Adriaens L, Brownstein CM, Lowy I, Kostic A, Trail PA, Gao B, DiCioccio AT, Siu LL (2016) A phase I first-in-human study of Nesvacumab (REGN910), a fully human anti-angiopoietin-2 (Ang2) monoclonal antibody, in patients with advanced solid tumors. Clin Cancer Res 22(6):1348\u20131355","journal-title":"Clin Cancer Res"},{"key":"6550_CR29","first-page":"37","volume":"2","author":"SE Pories","year":"2010","unstructured":"Pories SE, Wulf GM (2010) Evidence for the role of bevacizumab in the treatment of advanced metastatic breast cancer: a review. Breast Cancer (Dove Med Press) 2:37\u201344","journal-title":"Breast Cancer (Dove Med Press)"},{"issue":"2","key":"6550_CR30","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1007\/s40264-018-0776-6","volume":"42","author":"L Procaccio","year":"2019","unstructured":"Procaccio L, Damuzzo V, Di Sarra F, Russi A, Todino F, Dadduzio V, Bergamo F, Prete AA, Lonardi S, Prenen H, Palozzo AC, Loupakis F (2019) Safety and tolerability of anti-angiogenic protein kinase inhibitors and vascular-disrupting agents in cancer: focus on gastrointestinal malignancies. Drug Saf 42(2):159\u2013179","journal-title":"Drug Saf"},{"key":"6550_CR31","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.711776","volume":"11","author":"Y Shao","year":"2021","unstructured":"Shao Y, Jia H, Huang L, Li S, Wang C, Aikemu B, Yang G, Hong H, Yang X, Zhang S, Sun J, Zheng M (2021) An original ferroptosis-related gene signature effectively predicts the prognosis and clinical status for colorectal cancer patients. Front Oncol 11:711776","journal-title":"Front Oncol"},{"issue":"2","key":"6550_CR32","doi-asserted-by":"publisher","first-page":"685","DOI":"10.3892\/ijo.2014.2772","volume":"46","author":"A Shen","year":"2015","unstructured":"Shen A, Lin W, Chen Y, Liu L, Chen H, Zhuang Q, Lin J, Sferra TJ, Peng J (2015) Pien Tze Huang inhibits metastasis of human colorectal carcinoma cells via modulation of TGF-\u03b21\/ZEB\/miR-200 signaling network. Int J Oncol 46(2):685\u2013690","journal-title":"Int J Oncol"},{"issue":"3","key":"6550_CR33","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1097\/CAD.0000000000001445","volume":"34","author":"Y Shi","year":"2023","unstructured":"Shi Y, Zhu H, Jiang H, Yue H, Yuan F, Wang F (2023) Cancer-associated fibroblasts-derived exosomes from chemoresistant patients regulate cisplatin resistance and angiogenesis by delivering VEGFA in colorectal cancer. Anticancer Drugs 34(3):422\u2013430","journal-title":"Anticancer Drugs"},{"key":"6550_CR34","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1186\/1471-2407-8-320","volume":"8","author":"N Simiantonaki","year":"2008","unstructured":"Simiantonaki N, Taxeidis M, Jayasinghe C, Kurzik-Dumke U, Kirkpatrick CJ (2008) Hypoxia-inducible factor 1 alpha expression increases during colorectal carcinogenesis and tumor progression. BMC Cancer 8:320","journal-title":"BMC Cancer"},{"issue":"2","key":"6550_CR35","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.0037","volume":"4","author":"D Su","year":"2021","unstructured":"Su D, Wu B, Shi L (2021) Cost-effectiveness of Atezolizumab plus bevacizumab vs sorafenib as first-line treatment of unresectable hepatocellular carcinoma. JAMA Netw Open 4(2):e210037","journal-title":"JAMA Netw Open"},{"issue":"5","key":"6550_CR36","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1517\/13543784.2016.1161754","volume":"25","author":"M Tampellini","year":"2016","unstructured":"Tampellini M, Sonetto C, Scagliotti GV (2016) Novel anti-angiogenic therapeutic strategies in colorectal cancer. Expert Opin Investig Drugs 25(5):507\u2013520","journal-title":"Expert Opin Investig Drugs"},{"issue":"1","key":"6550_CR37","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1186\/s12935-021-01920-0","volume":"21","author":"Y Tang","year":"2021","unstructured":"Tang Y, Zong S, Zeng H, Ruan X, Yao L, Han S, Hou F (2021) MicroRNAs and angiogenesis: a new era for the management of colorectal cancer. Cancer Cell Int 21(1):221","journal-title":"Cancer Cell Int"},{"key":"6550_CR38","doi-asserted-by":"publisher","DOI":"10.1002\/jgm.3616","author":"CS Wang","year":"2023","unstructured":"Wang CS, Lee YC, Jhan JH, Li WM, Chang LL, Huang AM, Lin HH, Wu YR, Hsu WC, Ke HL (2023) MicroRNA-299-3p inhibits cell proliferation, motility, invasion and angiogenesis via VEGFA in upper tract urothelial carcinoma. J Gene Med. https:\/\/doi.org\/10.1002\/jgm.3616","journal-title":"J Gene Med"},{"key":"6550_CR39","doi-asserted-by":"publisher","first-page":"1187882","DOI":"10.3389\/fendo.2023.1187882","volume":"14","author":"WY Wu","year":"2023","unstructured":"Wu WY, Jiao X, Song WX, Wu P, Xiao PQ, Huang XF, Wang K, Zhan SF (2023) Network pharmacology and bioinformatics analysis identifies potential therapeutic targets of Naringenin against COVID-19\/LUSC. Front Endocrinol (Lausanne) 14:1187882","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"2","key":"6550_CR40","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.bbagrm.2012.11.006","volume":"1829","author":"Y Yin","year":"2013","unstructured":"Yin Y, Yan ZP, Lu NN, Xu Q, He J, Qian X, Yu J, Guan X, Jiang BH, Liu LZ (2013) Downregulation of miR-145 associated with cancer progression and VEGF transcriptional activation by targeting N-RAS and IRS1. Biochim Biophys Acta 1829(2):239\u2013247","journal-title":"Biochim Biophys Acta"},{"issue":"4","key":"6550_CR41","doi-asserted-by":"publisher","first-page":"1976","DOI":"10.3892\/or.2013.2633","volume":"30","author":"Y Zhang","year":"2013","unstructured":"Zhang Y, Wang X, Xu B, Wang B, Wang Z, Liang Y, Zhou J, Hu J, Jiang B (2013) Epigenetic silencing of miR-126 contributes to tumor invasion and angiogenesis in colorectal cancer. Oncol Rep 30(4):1976\u20131984","journal-title":"Oncol Rep"},{"key":"6550_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2020.111099","volume":"134","author":"N Zhang","year":"2021","unstructured":"Zhang N, Hu X, Du Y, Du J (2021) The role of miRNAs in colorectal cancer progression and chemoradiotherapy. Biomed Pharmacother 134:111099","journal-title":"Biomed Pharmacother"},{"key":"6550_CR43","doi-asserted-by":"publisher","first-page":"1103547","DOI":"10.3389\/fphar.2023.1103547","volume":"14","author":"C Zhang","year":"2023","unstructured":"Zhang C, Liu T, Yun Z, Liang B, Li X, Zhang J (2023) Identification of angiogenesis-related subtypes, the development of prognostic models, and the landscape of tumor microenvironment infiltration in colorectal cancer. Front Pharmacol 14:1103547","journal-title":"Front Pharmacol"},{"key":"6550_CR44","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23020852","author":"AL Zygulska","year":"2022","unstructured":"Zygulska AL, Pierzchalski P (2022) Novel diagnostic biomarkers in colorectal cancer. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms23020852","journal-title":"Int J Mol Sci"}],"container-title":["Journal of Cancer Research and Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00432-026-06550-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-026-06550-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-026-06550-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T22:46:26Z","timestamp":1791240386000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00432-026-06550-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,10]]},"references-count":44,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2026,10]]}},"alternative-id":["6550"],"URL":"https:\/\/doi.org\/10.1007\/s00432-026-06550-5","relation":{},"ISSN":["1432-1335"],"issn-type":[{"value":"1432-1335","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,10]]},"assertion":[{"value":"14 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This project was approved and supervised under the supervision of the ethics committee of Shahid Beheshti University of Medical Sciences in Tehran, Iran (ethics code: IR.SBMU.RETECH.REC.1402.128) and carried out following the guidelines of the National ethics committee.","order":2,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This manuscript\/data, or parts thereof, has not been submitted for possible publication to another journal and the work has previously been published elsewhere.","order":3,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"193"}}